Ironwood Pharmaceuticals, Inc.
IRWD
$1.27
$0.000.00%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 92.85M | 108.48M | 88.56M | 88.21M | 105.52M |
Total Receivables | 86.17M | 39.77M | 81.89M | 76.20M | 58.11M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 12.73M | 12.33M | 11.92M | 14.19M | 14.55M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 191.75M | 160.58M | 182.37M | 178.60M | 178.18M |
|
|||||
Total Current Assets | 191.75M | 160.58M | 182.37M | 178.60M | 178.18M |
Net Property, Plant & Equipment | 14.13M | 14.88M | 15.52M | 16.23M | 16.89M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 2.45M | 2.66M | 2.86M | 3.07M | 3.27M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 134.61M | 149.10M | 150.16M | 191.62M | 197.28M |
Total Assets | 342.95M | 327.21M | 350.91M | 389.52M | 395.62M |
|
|||||
Total Accounts Payable | 1.39M | 5.83M | 2.13M | 3.24M | 3.23M |
Total Accrued Expenses | 17.27M | 16.67M | 26.00M | 31.06M | 25.39M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 202.55M | 3.20M | 3.19M | 3.17M | 3.16M |
Total Finance Division Other Current Liabilities | 11.32M | 22.40M | 7.53M | 11.92M | 13.74M |
Total Other Current Liabilities | 11.32M | 22.40M | 7.53M | 11.92M | 13.74M |
Total Current Liabilities | 232.53M | 48.10M | 38.85M | 49.38M | 45.51M |
|
|||||
Total Current Liabilities | 232.53M | 48.10M | 38.85M | 49.38M | 45.51M |
Long-Term Debt | 385.00M | 584.16M | 583.99M | 598.82M | 623.65M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 11.12M | 11.72M | 12.30M | 12.88M | 13.45M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 22.47M | 17.29M | 17.11M | 39.77M | 34.74M |
Total Liabilities | 651.11M | 661.27M | 652.24M | 700.85M | 717.35M |
|
|||||
Common Stock & APIC | 1.41B | 1.40B | 1.40B | 1.39B | 1.38B |
Retained Earnings | -1.71B | -1.74B | -1.70B | -1.70B | -1.70B |
Treasury Stock & Other | -2.03M | 294.00K | 923.00K | -2.05M | -470.00K |
Total Common Equity | -308.16M | -334.05M | -301.34M | -311.33M | -321.73M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -308.16M | -334.05M | -301.34M | -311.33M | -321.73M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -308.16M | -334.05M | -301.34M | -311.33M | -321.73M |
|